Progesterone Capsule
Product Images NDC 42291-785

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Progesterone (NDC 42291-785). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Avkare, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

100 (784 01)

The label for Progesterone Capsules 100 mg shows it is an oral capsule product from AvKARE. The label warns not to use if allergic to peanuts and instructs pharmacists to dispense the patient information leaflet. It states each capsule contains 100 mg micronized progesterone, advises storage at controlled room temperature, and cautions to keep out of children's reach. The packaging contains 100 capsules and includes a barcode and manufacturing details noting it is a product of Spain.*

FDA Label Image

30 (784 30)

Packaging label of Progesterone Capsules 100 mg by AvKARE. The label indicates each capsule contains 100 mg micronized progesterone. It includes a warning not to use if allergic to peanuts and storage instructions. The package contains 30 capsules and is manufactured for AvKARE, Pulaski, TN, USA. Barcode and other labeling information are visible.*

FDA Label Image

100 (785 01)

Packaging label for Progesterone Capsules 200 mg in a 100-capsule container. The label includes warnings such as not to use if allergic to peanuts and provides storage instructions. The labeler is AvKARE, with manufacturing in Spain. The packaging includes a barcode and product identification details.*

FDA Label Image

30 (785 30)

Progesterone Capsules 200 mg oral capsules in a carton manufactured for AvKARE. The label includes storage instructions and a warning not to use if allergic to peanuts. The package contains 30 capsules and indicates it is a product of Spain. The label features dosage and handling information alongside the AvKARE logo and barcodes.*

FDA Label Image

Figure 1 (Figure 1)

A Kaplan-Meier curve chart illustrating the probability of hyperplasia over time (months) on medication. The chart compares three groups: patients on conjugated estrogens alone, those on conjugated estrogens plus micronized progesterone (cyclical), and those on placebo only. Sample sizes at various time points are indicated below the x-axis.*

FDA Label Image

Chemical Structure (Prog Structure)

Chemical structure of progesterone, the active ingredient in the product Progesterone capsules by AvKARE. The structure is a steroid hormone with four fused rings and functional groups typical of progesterone.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.